Orthopediatrics (KIDS) Liabilities and Shareholders Equity (2016 - 2026)

Orthopediatrics has reported Liabilities and Shareholders Equity for 11 years, with the latest figure at $502.2 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $502.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (up 7.75% YoY), and the FY2025 full-year result was $508.6 million, up 7.49% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $502.2 million, down from $508.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $508.6 million in Q4 2025, with the low at $301.0 million in Q1 2022.
• Average Liabilities and Shareholders Equity over 5 years is $443.0 million, with a median of $437.2 million recorded in 2024.
• Peak annual rise in Liabilities and Shareholders Equity reached 41.65% in 2022, while the deepest fall reached 3.94% in 2022.
• Tracing KIDS's Liabilities and Shareholders Equity over 5 years: stood at $427.7 million in 2022, then rose by 2.58% to $438.7 million in 2023, then grew by 7.86% to $473.2 million in 2024, then climbed by 7.49% to $508.6 million in 2025, then fell by 1.27% to $502.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $502.2 million (Q1 2026), $508.6 million (Q4 2025), and $493.5 million (Q3 2025), per Business Quant data.

Peer Comparison